Becton, dickinson and company:1106636 [16-013217]

Ended Awarded Last action

Contract number
HHSN261201600031U
Awardee
Awarding agency
Obligated
$18,559

Award facts

Contract value 100% obligated
$18,559.35 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$6,186
Original award $24,746

About this award

The National Cancer Institute issued a delivery order to Becton, Dickinson And Company on December 23, 2015, with a ceiling value of $18,559.35 and an ultimate completion date of February 19, 2017.

Place of performance is Bethesda, MD 20892. The order is priced on a firm fixed-price basis and was issued without a set-aside. Becton, Dickinson And Company, through its BD Biosciences division, supplies flow cytometry instruments, reagents, and consumables essential to biomedical research and clinical diagnostics across multiple federal agencies.

Quick answers

Who was awarded contract HHSN261201600031U?

HHSN261201600031U was awarded to Becton, Dickinson And Company by National Cancer Institute (National Institutes of Health) on December 23, 2015.

How much is contract HHSN261201600031U worth?

The government has obligated $18,559 on HHSN261201600031U.

Is contract HHSN261201600031U an order under another contract?

Yes. HHSN261201600031U is a delivery order under GS24F2044D, a federal supply schedule.

Was contract HHSN261201600031U competed?

The extent of competition for HHSN261201600031U was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award